**Question:** Aniridia is associated with -

A. Wilms' Tumor Gene (WT1)
B. Fuchs' Heterochromia
C. Cystinuria
D. Gorham-Stout Syndrome

**Answer Explanation:**

**Core Concept:** Aniridia is a rare genetic disorder characterized by the absence of iris pigment cells, leading to reduced or absent iris pigmentation, and potentially affecting vision. This condition is associated with mutations in specific genes that regulate eye development.

**Why the Correct Answer is Right:** Aniridia is primarily associated with mutations in the Wilms' Tumor Gene (WT1). WT1 is a transcription factor gene located on the short arm of chromosome 11 and plays a crucial role in the development of various tissues, including the kidney, genitalia, and the eye. In the context of eye development, WT1 regulates the expression of genes responsible for iris pigment cell differentiation and maintenance. Mutations in WT1 lead to defective iris pigment cell development, resulting in aniridia.

**Why Each Wrong Option is Incorrect:**

B. Fuchs' Heterochromia (heterochromia iridum) refers to the condition where the iris has different colors, not its absence. This is unrelated to aniridia.
C. Cystinuria is a genetic disorder causing the kidney and bladder to excrete excessive cystine, a sulfur-containing amino acid, leading to kidney stones and urinary tract infections. It is unrelated to aniridia.
D. Gorham-Stout Syndrome, also known as vascular gas gangrene, is characterized by the involuntary resorption of bone and replacement by blood vessels. This condition is distinct from aniridia, which is a separate entity affecting iris development.

**Clinical Pearl:** Understanding the genetic basis of aniridia, specifically mutations in the WT1 gene, is essential for recognizing and managing this rare condition. It is crucial for ophthalmologists, geneticists, and pediatricians to be familiar with aniridia, as it has implications for vision and potential developmental abnormalities in affected individuals.